1 active not recruiting, 1 completed, 1 recruiting, 1 terminated. 3 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow MAG-EPA: new trials by email Literature Review of MAG-EPA trials Research Report on MAG-EPA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA). Monoglyceride Eicosapentaenoic acid (omega-3), Sunflower Oil - Brain Fog, Cognitive Health | Phase 4 | Recruiting | Samuel Fortin | 48 | 2024-11-06 | 2025-12-11 |
| Impact of Fish Oil Monoglycerides on the Modulation of Mitochondrial Functions and Lactate Threshold Eicosapentaenoic acid + Docosahexaenoic acid, Eicosapentaenoic acid - Healthy Athletes | Phase 4 | Terminated | Samuel Fortin | 9 | 2019-09-19 | 2022-04-15 |
| Effect of Omega-3 Index on Cellular Metabolism and Quality of Life MAG-EPA - Healthy | Phase 4 | Completed | SCF Pharma | 16 | 2017-10-02 | 2019-04-04 |
| Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer. MAG-EPA, Placebo group - Prostate Cancer | Phase 2 | Active not recruiting | CHU de Quebec-Universite Laval | 39 | 2017-07-10 | 2025-12-19 |
Mental Fatigue (1) · Prostatic Neoplasms (1)
Samuel Fortin (2) · CHU de Quebec-Universite Laval (1) · SCF Pharma (1)
Canada (4)